Michael Bigham, Chairman and CEO at Paratek Pharmaceuticals, Inc. (PRTK), bought 20,000 shares at $13.45 ($269K) on 2016-06-23, disclosed to the SEC on 2016-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |